Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: a call to …
V Pavoni, L Gianesello, M Pazzi, C Stera, T Meconi… - Thrombosis research, 2020 - Elsevier
Background Critically ill COVID-19 patients have a clear pattern of inflammation and
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …
[HTML][HTML] Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study
J Helms, F Severac, H Merdji, M Schenck… - Annals of intensive …, 2021 - Springer
Background Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed
to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute …
to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute …
[HTML][HTML] Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19
MG Mennuni, G Renda, L Grisafi, A Rognoni… - Journal of thrombosis …, 2021 - Springer
A pro-thrombotic milieu and a higher risk of thrombotic events were observed in patients with
CoronaVirus disease-19 (COVID-19). Accordingly, recent data suggested a beneficial role of …
CoronaVirus disease-19 (COVID-19). Accordingly, recent data suggested a beneficial role of …
[HTML][HTML] Safety of intermediate dose of low molecular weight heparin in COVID-19 patients
M Mattioli, D Benfaremo, M Mancini, L Mucci… - Journal of thrombosis …, 2021 - Springer
Coagulopathy represents one of the most important determinants of morbidity and mortality
in coronavirus disease-19 (COVID-19). Whether standard thromboprophylaxis is sufficient or …
in coronavirus disease-19 (COVID-19). Whether standard thromboprophylaxis is sufficient or …
[HTML][HTML] The versatile heparin in COVID‐19
J Thachil - Journal of Thrombosis and Haemostasis, 2020 - jthjournal.org
Coagulopathy in coronavirus infection has been shown to be associated with high mortality
with high D-dimers being a particularly important marker for the coagulopathy. 1 In the latest …
with high D-dimers being a particularly important marker for the coagulopathy. 1 In the latest …
[HTML][HTML] Venous thrombo-embolism in hospitalized SARS-CoV-2 patients treated with three different anticoagulation protocols: prospective observational study
Y Longhitano, F Racca, C Zanza, M Muncinelli… - Biology, 2020 - mdpi.com
Simple Summary The aims of this study are:(1) to analyze the risk of vein thrombosis and
pulmonary embolism in patients affected by pneumonia due to Covid-19;(2) to evaluate …
pulmonary embolism in patients affected by pneumonia due to Covid-19;(2) to evaluate …
[HTML][HTML] Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19
We conducted an observational cohort study in adult patients consecutively admitted for the
respiratory illness Covid-19 to our hub hospital from March 9 to April 7, 2020. The high …
respiratory illness Covid-19 to our hub hospital from March 9 to April 7, 2020. The high …
[HTML][HTML] Major bleeding complications in critically ill patients with COVID-19 pneumonia
A Godier, D Clausse, S Meslin, M Bazine… - Journal of thrombosis …, 2021 - Springer
As patients with COVID-19 pneumonia admitted to intensive care unit (ICU) have high rates
of thrombosis, high doses of thromboprophylaxis have been proposed. The associated …
of thrombosis, high doses of thromboprophylaxis have been proposed. The associated …
Thromboinflammation and the hypercoagulability of COVID‐19
JM Connors, JH Levy - Journal of thrombosis and haemostasis, 2020 - jthjournal.org
The pathogenic coronavirus has been wreaking havoc worldwide since January. Infection
with SARS-CoV-2 is problematic as no one has prior immunity, and no specific antiviral …
with SARS-CoV-2 is problematic as no one has prior immunity, and no specific antiviral …
[HTML][HTML] Prevalence and predictors of venous thromboembolism or mortality in hospitalized COVID-19 patients
Background We aimed to identify the prevalence and predictors of venous
thromboembolism (VTE) or mortality in hospitalized coronavirus disease 2019 (COVID-19) …
thromboembolism (VTE) or mortality in hospitalized coronavirus disease 2019 (COVID-19) …